22d2d308d123835f8f50fbf864e930c1

HEMOSIL ACUSTAR ANTI-ß2 GLYCOPROTEIN-I IGM CONTROLS

WERFEN COLOMBIA SAS·Colombia INVIMA·Expires September 16, 2031

Device classification

Product type (Spanish): REACTIVO DIAGNOSTICO
Product type (English): DIAGNOSTIC REAGENT

Registration information

Analysis ID: 22d2d308d123835f8f50fbf864e930c1
Expire date: September 16, 2031

Authorized company / Fabricante

Name (Spanish): WERFEN COLOMBIA SAS
Name (English): THROW COLOMBIA SAS

About this record

Access comprehensive regulatory information for HEMOSIL ACUSTAR ANTI-ß2 GLYCOPROTEIN-I IGM CONTROLS (HEMOSIL ACUSTAR ANTI-ß2 GLYCOPROTEIN-I IGM CONTROLS) in the Colombia medical device market through Pure Global AI's free database. This medical device is registered under INVIMA analysis ID 22d2d308d123835f8f50fbf864e930c1 and manufactured by WERFEN COLOMBIA SAS. The device was registered on September 16, 2031.

This page provides complete registration details including product type (DIAGNOSTIC REAGENT), authorised information, and regulatory compliance data from the official Colombia INVIMA medical device database. Pure Global AI offers free access to Colombia's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate INVIMA regulations efficiently.